Showing results (51-60 of 100) with videos related to
Sort By:
Pageof 10
Drug Research|April 27, 2017
Central and Peripheral Glucagon Reduces Hyperlipidemia in Rats and HamstersVishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, et al.Pathogens and Global Health|March 20, 2024
Immunization of laboratory animal workers: occupational health and safety aspectsLaxit K Bhatt, Jitendra H Patel, Chitrang R Shah, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2008
Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligandsSaurin Raval, Preeti Raval, Debdutta Bandyopadhyay, et al.Drug Development Research|April 7, 2025
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's BloodVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 12, 2017
Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γ agonist for treatment of dyslipidemia and metabolic disordersHarilal Patel, Poonam Giri, Prakash Patel, et al.International Immunopharmacology|August 31, 2024
Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in miceVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.Inflammopharmacology|November 23, 2024
Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammationVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.International Immunopharmacology|July 3, 2013
Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitisManoranjan Sharma, Jogeswar Mohapatra, Umar Malik, et al.Bioorganic & Medicinal Chemistry|June 23, 2007
Synthesis of 3,8,9-trisubstituted-1,7,9-triaza-fluorene-6-carboxylic acid derivatives as a new class of insulin secretagoguesRajesh H Bahekar, Mukul R Jain, Pradip A Jadav, et al.Bioorganic & Medicinal Chemistry Letters|September 27, 2020
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitorSameer Agarwal, Jignesh P Pethani, Hardik A Shah, et al.Pageof 10